Intrexon Profile

13.25
USD 0.37  2.72%
12.01
52%
14.36
13.18
15%
13.65

Intrexon exotic insider transaction detected

Intrexon Corporation insider trading alert for general transaction of common stock by Randal Kirk, Chief Executive Officer, on February 16, 2018. This event was filed by Intrexon Corp with SEC on 2014-03-31. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Intrexon Summary

Intrexon Corporation (XON) is traded on New York Stock Exchange in USA. It is located in VIRGINIA, U.S.A and employs 832 people. Intrexon is listed under Business Services category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with total capitalization of 1.69 B. Intrexon Corporation runs under Healthcare sector within Business Services industry. This company has 127.52 M outstanding shares of which 20.38 M shares are at this time shorted by investors with about 11.58 days to cover shorted positions. Intrexon Corporat has about 108.72 M in cash with (94.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.9.
Check Intrexon Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Intrexon Corporation Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Intrexon Against Markets

Current Ratings

Intrexon 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
< 55% 
Equity ratings for Intrexon Corporation are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Intrexon Corporation operates in the synthetic biology field in the United States. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland. Intrexon operates under Biotechnology classification in USA and traded on New York Stock Exchange exchange. It employs 832 people. more
Fama & French Business Services
Business Services
Fama & French Classification
NameIntrexon Corporation
Chairman of the Board, CEORandal KirkAll Leadership
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationVIRGINIA, U.S.A
Business Address20374 Seneca Meadows Parkway
ExchangeNew York Stock Exchange
CIK Number01356090.0
CUSIP46122T102
SectorHealthcare
IndustryBusiness Services
BenchmarkDOW
Websitewww.dna.com
Contact Number301 556 9900
CurrencyUSD - US Dollar

Recommendations

Intrexon Analyst Recommendations
Target PriceAdvice# of Analysts
44.14Buy7Odds
Intrexon Corporation current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Intrexon Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Intrexon Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.23March 1, 2017
Intrexon Corporation normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

Intrexon Corporate Directors
Steven Frank Independent Director, MBA
Cesar Alvarez Independent Director
Dean Mitchell Independent Director